Pyrrolizidine alkaloid-induced alterations of prostanoid synthesis in human endothelial cells.


Journal

Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276

Informations de publication

Date de publication:
25 Jan 2019
Historique:
received: 16 08 2018
revised: 08 10 2018
accepted: 13 11 2018
pubmed: 23 11 2018
medline: 10 1 2019
entrez: 23 11 2018
Statut: ppublish

Résumé

Pyrrolizidine alkaloids (PA) are a group of secondary plant metabolites belonging to the most widely distributed natural toxins. PA intoxication of humans leads to severe liver damage, such as hepatomegaly, hepatic necrosis, fibrosis and cirrhosis. An acute consequence observed after ingestion of high amounts of PA is veno-occlusive disease (VOD) where the hepatic sinusoidal endothelial cells are affected. However, the mechanisms leading to VOD after PA intoxication remain predominantly unknown. Thus, we investigated PA-induced molecular effects on human umbilical vein endothelial cells (HUVEC). We compared the effects of PA with the effects of PA metabolites obtained by in vitro metabolism using liver homogenate (S9 fraction). In vitro-metabolized lasiocarpine and senecionine resulted in significant cytotoxic effects in HUVEC starting at 300 μM. Initial molecular effect screening using a PCR array with genes associated with endothelial cell biology showed PA-induced upregulation of the Fas receptor, which is involved in extrinsic apoptosis, and regulation of a number of interleukins, as well as of different enzymes relevant for prostanoid synthesis. Modulation of prostanoid synthesis was subsequently studied at the mRNA and protein levels and verified by increased release of prostaglandin I

Identifiants

pubmed: 30465738
pii: S0009-2797(18)31077-9
doi: 10.1016/j.cbi.2018.11.007
pii:
doi:

Substances chimiques

Prostaglandins 0
Pyrrolizidine Alkaloids 0
Thromboxane A2 57576-52-0
Cytochrome P-450 Enzyme System 9035-51-2
senecionine BO6N1U5YG6
Epoprostenol DCR9Z582X0
Cyclooxygenase 2 EC 1.14.99.1
PTGS2 protein, human EC 1.14.99.1
PTGIS protein, human EC 5.3.99.4
lasiocarpine S770100Q96

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-111

Informations de copyright

© 2018 Elsevier B.V. All rights reserved.

Auteurs

Johanna Ebmeyer (J)

German Federal Institute for Risk Assessment, Department Food Safety, Berlin, Germany.

Jessica Behrend (J)

German Federal Institute for Risk Assessment, Department Food Safety, Berlin, Germany.

Mario Lorenz (M)

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Medizinische Klinik für Kardiologie und Angiologie, Campus Mitte, Berlin, Germany.

Georgia Günther (G)

Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany.

Raymond Reif (R)

Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany.

Jan G Hengstler (JG)

Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany.

Albert Braeuning (A)

German Federal Institute for Risk Assessment, Department Food Safety, Berlin, Germany.

Alfonso Lampen (A)

German Federal Institute for Risk Assessment, Department Food Safety, Berlin, Germany.

Stefanie Hessel-Pras (S)

German Federal Institute for Risk Assessment, Department Food Safety, Berlin, Germany. Electronic address: stefanie.hessel-pras@bfr.bund.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH